Cytiva Denmark Manufacturing ApS: Financial statements 2018
CVR: 21595888
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Cytiva Denmark Manufacturing ApS (CVR 21595888) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 5,051,046 and a net result of DKK 1,953,326 compared with DKK 2,144,323 the year before. That is an increase of 4.1% compared with the year before. Equity in the 2018 report amounted to DKK 67,349,217. The solvency ratio was 89.7%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 5,051,046
- Profit/Loss
- DKK 1,953,326
- Equity
- DKK 67,349,217
- Total Assets
- DKK 75,063,340
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 5.1M | 2M | 67.3M | 16 |
| 2017 | - | 4.9M | 2.1M | 65.4M | - |
| 2016 | - | 4.7M | 1.9M | 63.3M | - |
| 2015 | - | 6.2M | 1.6M | 61.3M | - |
| 2014 | - | 5.8M | 1.6M | 59.7M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 22, 2018, KPMG P/S has been appointed auditor of Cytiva Denmark Manufacturing ApS.
As of November 22, 2018, AsLa Revision ApS has stepped down as auditor of Cytiva Denmark Manufacturing ApS.
As of July 15, 2018, Ralf Manfred Geier-Cibin has joined the board of directors of Cytiva Denmark Manufacturing ApS.
As of July 15, 2018, Rodolfo Jose Savitzky has left the board of directors of Cytiva Denmark Manufacturing ApS.
Cytiva Denmark Manufacturing ApS has published its annual report for 2017. Gross profit came to DKK 4,852,853, and the net result was DKK 2,144,323.
About Cytiva Denmark Manufacturing ApS
Cytiva Denmark Manufacturing ApS is a Danish company of the type Anpartsselskab based in Vallensbæk Strand, founded in 1999. The company is registered under the industry Fremstilling af plast i ubearbejdet form. The company was previously named LONZA COPENHAGEN ApS and CAMBREX BIO SCIENCE COPENHAGEN ApS. The management consists of Henrik Larsen. The board consists of Henrik Larsen (chair), Manuel Valiente Stegeman and Per Jonas Jakstad. The company is owned by GLS Sweden Holdings AB. The company has 22 employees (2026). In 2025, the company reported a gross profit of DKK -7,710,228 and a net result of DKK -6,828,245 compared with DKK -20,102,401 the year before. Equity in the 2025 report amounted to DKK 827,334,352.
